References
- 1Beagley J, Guariguata L, Weil C and Motala AA. Global estimates of undiagnosed diabetes in adults. Diabetes Research and Clinical Practice. 2014; 103(2): 150–60. DOI: 10.1016/j.diabres.2013.11.001
- 2International Diabetes Federation. IDF Diabetes Atlas, Seventh Edition; 2015.
http://www.diabetesatlas.org . Accessed December 25, 2015. - 3American Diabetes Association. Classification and diagnosis of diabetes. Sec. 2. In: Standards of Medical Care in Diabetes, 2015. Diabetes Care. 2015; 38(Suppl. 1): S8–S16.
- 4Bonora E and Tuomilehto J. The pros and cons of diagnosing diabetes with A1C. Diabetes Care. 2011; 34(Suppl 2): S184–90. DOI: 10.2337/dc11-s216
- 5Whitley HP, Yong EV and Rasinen C. Selecting an A1C point-of-care instrument. Diabetes Spectrum: A Publication of the American Diabetes Association. 2015; 28(3): 201–8. DOI: 10.2337/diaspect.28.3.201
- 6Lenters-Westra E and Slingerland RJ. Three of 7 hemoglobin A1c point-of-care instruments do not meet generally accepted analytical performance criteria. Clinical Chemistry. 2014; 60(8): 1062–72. DOI: 10.1373/clinchem.2014.224311
- 7National Glycohemoglobin Standardization Program. List of NGSP Certified Methods, updated 12/15; 2015.
http://www.ngsp.org/docs/methods.pdf . Accessed December 25, 2015. - 8College of American Pathologists. College of American Pathologists (CAP) GH5 Survey Data: (updated 8/15); 2015.
http://www.ngsp.org/CAP/CAP15b.pdf . Accessed December 25, 2015. - 9Saldarriaga EM, Vodicka E, La Rosa S, Valderrama M and Garcia PJ. Point-of-care testing for anemia, diabetes, and hypertension: A pharmacy-based model in Lima, Peru. Annals of Global Health. 2017; 83(2): 394–404. DOI: 10.1016/j.aogh.2017.03.514
- 10Ministerio de Salud de Peru (MINSA). Informacion Estadistica; 2015.
http://www.minsa.gob.pe/index.asp?op=6 . Accessed December 26, 2015. - 11Institute Nacional de Estadistica E Informatica. Peru: Enfermedades no transmisibles y transmisibles, 2014; 2015.
http://www.inei.gob.pe/media/MenuRecursivo/publicaciones_digitales/Est/Lib1212/Libro.pdf . Accessed December 25, 2015. - 12Alere Technologies AS. Afinion package insert; 2015.
http://www.cliawaived.com/web/items/pdf/ABBT-06L13-10insert.pdf . Accessed December 25, 2015. - 13Alere Technologies AS.
Alere Afinion AS 100 Analyzer User Manual . Oslo, Norway; 2014. - 14Siemens Medical Solutions USA I. DCA Vantage Analyzer Technical Specifications; 2015.
http://usa.healthcare.siemens.com/point-of-care/diabetes/dca-vantage-analyzer/technical-specifications . Accessed December 25, 2015. - 15Hoelzel W, Weykamp C, Jeppsson JO, et al. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: A method-comparison study. Clinical Chemistry. 2004; 50(1): 166–74. DOI: 10.1373/clinchem.2003.024802
- 16Petersen JR, Omoruyi FO, Mohammad AA, Shea TJ, Okorodudu AO and Ju H. Hemoglobin A1c: Assessment of three POC analyzers relative to a central laboratory method. Clinica Chimica Acta: International Journal of Clinical Chemistry. 2010; 411(23–24): 2062–6.
- 17Malkani S, Korpi-Steiner N and Rao LV. Reducing analytical variation between point-of-care and laboratory HbA1c testing. Journal of Diabetes. 2013; 5(2): 192–6. DOI: 10.1111/1753-0407.12009
- 18Szymezak J, Leroy N, Lavalard E and Gillery P. Evaluation of the DCA Vantage analyzer for HbA 1c assay. Clinical Chemistry and Laboratory Medicine. 2008; 46(8): 1195–8. DOI: 10.1515/CCLM.2008.228
- 19Torregrosa ME, Molina J, Argente CR and Ena J. Accuracy of three hemoglobin A1c point-of-care systems for glucose monitoring in patients with diabetes mellitus. Endocrinologia y nutricion: organo de la Sociedad Espanola de Endocrinologia y Nutricion. 2015; 62(10): 478–84. DOI: 10.1016/j.endonu.2015.07.007
- 20Font MT, Brichs MC, Alvarez MC, Olivella JM, Turo JS and Fernandez MP. Capillary HbA1c determination on type 2 diabetes patients in a primary health centre. Atencion primaria/Sociedad Espanola de Medicina de Familia y Comunitaria. 2011; 43(10): 536–43.
- 21Lenters-Westra E and Slingerland RJ. Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria. Clinical Chemistry. 2010; 56(1): 44–52. DOI: 10.1373/clinchem.2009.130641
- 22Lee JY, Hong KS and Cho SE. Comparison of HbA1c analyzers: D-10, Variant II Turbo, Cobas Integra 800, and Afinion AS100. The Korean Journal of Laboratory Medicine. 2010; 30(4): 345–50. DOI: 10.3343/kjlm.2010.30.4.345
- 23Solvik UO, Roraas T, Christensen NG and Sandberg S. Diagnosing diabetes mellitus: Performance of hemoglobin A1c point-of-care instruments in general practice offices. Clinical Chemistry. 2013; 59(12): 1790–801. DOI: 10.1373/clinchem.2013.210781
- 24Wan Mohd Zin RM, Ahmad Kamil ZI, Tuan Soh TR, Embong M and Wan Mohamud WN. Haemoglobin A1c: Comparing performance of two point-of-care devices with laboratory analyser. BMC Research Notes. 2013; 6: 540. DOI: 10.1186/1756-0500-6-540
- 25Wood JR, Kaminski BM, Kollman C, et al. Accuracy and precision of the Axis-Shield Afinion hemoglobin A1c measurement device. Journal of Diabetes Science and Technology. 2012; 6(2): 380–6. DOI: 10.1177/193229681200600224
- 26Sanchez-Mora C, Rodríguez-Oliva MS, Fernandez-Riejos P, et al. Evaluation of two HbA1c point-of-care analyzers. Clinical Chemistry and Laboratory Medicine. 2011; 49(4): 653–7. DOI: 10.1515/CCLM.2011.101
- 27Lenters-Westra E and Slingerland RJ. Evaluation of the Quo-Test hemoglobin A1c point-of-care instrument: Second chance. Clinical Chemistry. 2010; 56(7): 1191–3. DOI: 10.1373/clinchem.2010.143149
- 28El Arabi H, Willems D, Melot C and Dorchy H. Evaluation of DCA vantage for rapid in-clinic measurement of HbA1c on capillary blood in young type 1 diabetic patients. Revue medicale de Bruxelles. 2013; 34(2): 87–9.
- 29Little RR. Analysis of the accuracy and precision of the Axis-Shield Afinion hemoglobin A1c measurement device. Journal of Diabetes Science and Technology. 2012; 6(2): 387–8. DOI: 10.1177/193229681200600225